SCHEMBL25870323

SCHEMBL25870323

COC(=O)[C@@H]1[C@@H](c2cc(C)cc(C(F)(F)F)c2)C1(Cl)Cl

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
ALDH1A1 P00352 1/20 0.36
RECQL P46063 1/20 0.36
GPR35 Q9HC97 2/20 0.35
HTT P42858 3/20 0.35
LMNA P02545 2/20 0.35
HPGD P15428 1/20 0.35
GUSB P08236 1/20 0.35
NOTUM Q6P988 1/20 0.34
TAS2R14 Q9NYV8 1/20 0.34
FFAR4 Q5NUL3 1/20 0.34
MAPT P10636 3/20 0.33
TDP1 Q9NUW8 1/20 0.33
GAA P10253 1/20 0.33
CACNA1F O60840 1/20 0.32
CACNA1D Q01668 1/20 0.32
CACNA1S Q13698 1/20 0.32
CACNA1C Q13936 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23933316 0.92 GPR35 (0.38) MEN1KMT2AALDH1A1RECQLGPR35
SCHEMBL23961570 0.92 GPR35 (0.38) MEN1KMT2AALDH1A1RECQLGPR35
SCHEMBL23933304 0.92 GPR35 (0.38) MEN1KMT2AALDH1A1RECQLGPR35
SCHEMBL25870348 0.87 GPR35 (0.39) MEN1KMT2AALDH1A1GPR35LMNA
SCHEMBL25870304 0.85 FFAR4 (0.40) MEN1KMT2AALDH1A1RECQLGPR35
SCHEMBL23466013 0.85 FFAR4 (0.40) MEN1KMT2AALDH1A1RECQLGPR35
SCHEMBL23961574 0.80 GPR35 (0.41) MEN1KMT2AALDH1A1GPR35LMNA
SCHEMBL23933310 0.80 GPR35 (0.41) MEN1KMT2AALDH1A1GPR35LMNA
SCHEMBL23933307 0.80 GPR35 (0.41) MEN1KMT2AALDH1A1GPR35LMNA
SCHEMBL18144169 0.74 CES2 (0.40) MEN1KMT2AALDH1A1RECQLGPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230220427-A1 PROCESSES RELATED TO FORMATION OF ARYLCYCLOPROPYL CARBOXYLIC ACIDS CORTEVA AGRISCIENCE LLC (US) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230220427-A1 PROCESSES RELATED TO FORMATION OF ARYLCYCLOPROPYL CARBOXYLIC ACIDS DDT, PCCA, DDC MEN1 4793/4885KMT2A 3122/4885ALDH1A1 72/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.